Gildess 1.5/30 (Par Pharmaceutical)


Welcome to the PulseAid listing for the Gildess 1.5/30 drug offered from Par Pharmaceutical. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical
NON-PROPRIETARY NAME: norethindrone acetate and ethinyl estradiol
SUBSTANCE NAME: NORETHINDRONE ACETATE; ETHINYL ESTRADIOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-07-24
END MARKETING DATE: 2018-03-31


Gildess 1.5/30 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGildess 1.5/30 from Par Pharmaceutical
LABELER NAME: Par Pharmaceutical
DEA SCHEDULE:
ACTIVE STRENGTH: 1.5; .03(mg/1; mg/1)
START MARKETING DATE: 2012-07-24
END MARKETING DATE: 2018-03-31
PRODUCT ID: 0603-7606_2f9ea569-030d-49fc-9181-0594d07bab53
PRODUCT NDC: 0603-7606
APPLICATION NUMBER: ANDA077075

Other NORETHINDRONE ACETATE; ETHINYL ESTRADIOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Jevantique Lo
Allergan, Inc.femhrt
Aurobindo Pharma LimitedAurovela 1.5/30
Barr Laboratories Inc.Junel 1/20
Glenmark Pharmaceuticals Inc., USANorethindrone Acetate and Ethinyl Estradiol
Mayne Pharma Inc.MICROGESTIN 1/20
Nivagen Pharmaceuticals, Inc.Norethindrone Acetate and Ethinyl Estradiol
Par PharmaceuticalGildess 1.5/30
Physicians Total Care, Inc.femhrt
Teva Pharmaceuticals USA IncJinteli
Teva Women’s Health, Inc.LOESTRIN 21 1.5/30